HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.
The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.
The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.
The Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI, says Dr. Baligh Yehia, president of Jefferson Health.
MENA-based healthcare organizations are creating fully connected digital ecosystems and shifting to value-based care. Because of this, Mazin Gadir of Alvarez & Marsal says basic EMRs are no longer enough for these health systems.
Surgeon and futurist Dr. Shafi Ahmed talks about how AI is shaping healthcare's future, including its use in digital surgery, drug development, wearables, genomic medicine and clinical decision support.
DeepLook Medical CEO Marissa Fayer cautions against using ChatGPT for medical advice and advocates for a balance between using digital technologies to empower patients and ensuring physicians remain trusted decision-makers.
Todd Van Meter, CEO of Accuity, says that when partnering with clients, initial clinical denial rates are nearly cut in half and following an appeals process using an AI-driven platform, the final denial rates end up at 1% to 1.5%.
For the year ahead, we'll be watching for precision medicine advances, cybersecurity challenges, policy shifts and, of course, continued evolution of AI-enabled care delivery, say the editors of the HIMSS Media brands.
Join the editors of the HIMSS Media brands for a wide-ranging discussion about an eventful 2025 for digital health transformation: regulatory and reimbursement changes, cybersecurity challenges and, yes, a whole lot of AI.
Brigham Hyde, CEO of Atropos Health, discusses the rollout of its AI Evidence Agent within Microsoft Teams, which allows care teams to access real-time, patient-specific insights during meetings to drive evidence-based clinical decisions.
Kevin Ritter, EVP for CareInMotion at Altera Digital Health, offers some answers and discusses how to tackle the challenges of data fragmentation and silos that block a unified patient view and impede coordinated care.